MBI PD-103 SL; MBI PD-103 SH— 510(k) K011427
Substantially EquivalentMills Biopharmaceuticals, Inc.
FDA 510(k) clearance K011427 for MBI PD-103 SL; MBI PD-103 SH, Substantially Equivalent on 2001-08-31. Applicant: Mills Biopharmaceuticals, Inc.. Device class: 2.
Clearance details
- Applicant
- Mills Biopharmaceuticals, Inc.
- Product code
- Code KXK
- Device class
- Class 2
- Regulation
- 21 CFR 892.5730
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Oklahoma City, OK, US
Recent devices under product code KXK
view allData sourced from openFDA. This site is unofficial and independent of the FDA.